HanchorBio Inc. (TPE:7827)

Market Cap	20.67B
Revenue (ttm)	312.22M
Net Income	-497.62M
EPS	-4.43
Shares Out	130.01M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,262,383
Open	163.00
Previous Close	164.50
Day's Range	148.50 - 164.00
52-Week Range	41.80 - 179.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About HanchorBio

HanchorBio Inc. operates as a biotechnology company that develops biologics for cancer patients. The company offers FBDB platform to develop biological medicines. The company also engages in novel target research and evaluation, development of in vitro and in vivo models for evaluating the bioactivities of anti-cancer drugs, and development of proteins. HanchorBio Inc. was founded in 2020 and is based in Taipei, Taiwan with an additional office in Shanghai, China.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2020
• Country: Cayman Islands
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 7827

Financial Performance

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jun 23, 2026

Data Sources Report a data error